alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    EXHIBIT 32.2

                             STRATEX NETWORKS, INC.

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                  PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the periodic report of Stratex Networks, Inc. (the "Company")
on Form 10-Q for the period ended June 30, 2003 as filed with the Securities and
Exchange Commission (the "Report"), I, Carl A. Thomsen, Chief Financial Officer
of the Company, hereby certify as of the date hereof, solely for purposes of
Title 18, Chapter 63, Section 1350 of the United States Code, that to the best
of my knowledge:

              (1) the Report fully complies with the requirements of Section
              13(a) or 15(d), as applicable, of the Securities Exchange Act of
              1934, and

              (2) the information contained in the Report fairly presents, in
              all material respects, the financial condition and results of
              operations of the Company at the dates and for the periods
              indicated.

Date: August 13, 2003                       /s/      Carl A. Thomsen
                                            ---------------------------
                                                     Carl A. Thomsen
                                                Chief Financial Officer
Exhibit 10.31  



	[EntreMed Logo]	 	www.entremed.com




May
24, 2006 


Affymax, Inc.

4001 Miranda Avenue

Palo Alto, California 94304

Attn: Robert Naso, Ph.D.

          Executive Vice President, R&D 


Re:     Fourth Extension of Letter Agreement


Dear
Bob: 


        I
am writing with reference to the Letter Agreement between Affymax, Inc. ("Affymax") and EntreMed, Inc. ("EntreMed") dated as of September 20, 2004 (together with
each of the exhibits thereto, the "Letter Agreement") and the related First Extension Letter dated as of August 23, 2005 between Affymax and EntreMed (the "First Extension Letter"),
pursuant to which EntreMed and Affymax agreed to extend the Term of the Letter Agreement to December 31, 2005, and the subsequent Second Extension Letter dated as of December 19, 2005
between Affymax and EntreMed (the "Second
Extension Letter"), pursuant to which EntreMed and Affymax agreed to further extend the Term of the Letter Agreement to February 28, 2006, and the subsequent Third Extension Letter dated as of
February 28, 2006 between Affymax and EntreMed (the "Third Extension Letter"), pursuant to which EntreMed and Affymax agreed to further extend the Term of the Letter Agreement to May 31,
2006. All capitalized terms used but not defined herein shall have the meaning given to such terms in the Letter Agreement. 



        As
both parties would like to continue the Research Collaboration under the Letter Agreement, pending our current negotiations relating to a Co-Development Agreement, the
Term of the Letter Agreement is agreed to be further extended until August 31, 2006. Both Affymax and EntreMed acknowledge and agree that, except as otherwise set forth in herein, all terms and
conditions of the Letter Agreement, the First Extension Letter, the Second Extension Letter and Third Extension Letter would remain unchanged and in full force and effect. 


        Please
confirm your agreement to extend the Term of the Letter Agreement (including, without limitation, the period to enter into a Co-Development Agreement) to
August 31, 2006, by countersigning this Letter and returning the countersigned letter to EntreMed. 



	 	 	Very truly yours,
	
 	
 	

EntreMed, Inc.
	
 	
 	

By:	

/s/ Marc Corrado
 Name: Marc Corrado

Title: Vice President







	 ACCEPTED AND AGREED:	 	 
	
 Affymax, Inc.	
 	

 
	
 By:	

/s/ Christopher Dammann
 Name: Christopher Dammann

Title: V.P. Business Development

Date: June 1st, 2006

	
 	

 




EntreMed,
Inc. / 9640 Medical Center Drive / Rockville, MD 20850

240.864.2600 phone / 240.864.2601 fax
#### MILLER, Respondent, v. CITY OF NEW YORK, Appellant.

(Supreme Court, Appellate Division, Second Department.

June 26, 1914.)

Action by Carrie Miller, an infant, by Elizabeth Miller, her guardian ad litem, against the City of New York.

PER CURIAM.

Judgment and order affirmed, with costs.

JENKS, P. J., and BURR, J., dissent, for error in refusing to charge as requested at folios 291 and 293.
#### § 801.220 What contracts and subcontracts, in addition to those listed in 2 CFR 180.220, are covered transactions?

VA does not extend coverage of nonprocurement suspension and debarment requirements beyond first-tier procurement contracts under a covered nonprocurement transaction, although the OMB guidance at 2 CFR 180.220(c) allows a Federal agency to do so (also see optional lower tier coverage in the figure in the appendix to 2 CFR part 180).
#### RODRIGUEZ v. INTERBOROUGH RAPID TRANSIT CO.

(Supreme Court, Appellate Division, First Department.

July 10, 1914.)

Action by Santiago Rodriguez against the Inter-borough Rapid Transit Company.

No opinion. Application denied, with $10 costs. Order signed. See, also, 85 Misc. Rep. 366, 147 N. Y. Supp. 242.
IN THE SUPREME COURT OF THE STATE OF NEVADA 

STEVE SISOLAK, GOVERNOR OF 

NEVADA; AARON D. FORD, 

ATTORNEY GENERAL OF NEVADA; 

GEORGE TOGLIATTI, DIRECTOR OF 

THE NEVADA DEPARTMENT OF 

PUBLIC SAFETY; AND MINDY 

MCKAY, ADMINISTRATOR OF THE 

RECORDS, COMMUNICATIONS, AND 

COMPLIANCE DIVISION OF THE 

NEVADA DEPARTMENT OF PUBLIC 

SAFETY, 

Appellants, 

vs. 

POLYMER80, INC., 

Res s ondent. 

No. 83385 

FILED 

JAN 2 4 2022 

ectrL 

 E F u t

E L. Z A B

ogt tf

l: o

c

r At

c

4 

jar 

ORDER DISMISSING APPEAL 

Appellants have filed a document titled "Notice of Mootness." 

In that document, appellants state that this appeal should be dismissed as 

moot. No response has been filed. Accordingly, appellants' request that this 

appeal be dismissed is granted. This appeal is dismissed. See NRAP 42(b). 

It is so ORDERED. 

C.J. 

cc: Hon. John Schlegelmilch, District Judge 

Attorney General/Carson City 

Attorney General/Las Vegas 

Simons Hall Johnston PC/Yerington 

Third District Court Clerk 

SUPREME COURT 

OF 

Newton 

(o) 1947A .s.10. ,O.P4R0
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

EDWARD WALKER,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D17-1107

[July 26, 2018]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Paul L. Backman, Judge; L.T. Case Nos. 98-8741CF10A, 

98-9012CF10A, 98-15893CF10A and 99-20178CF10A.

Edward Walker, Raiford, pro se.

Pamela Jo Bondi, Attorney General, Tallahassee, and James J. Carney, 

Senior Assistant Attorney General, West Palm Beach, for appellee.

PER CURIAM.

Affirmed.

WARNER, GROSS and TAYLOR, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
**EXHIBIT
      31.2**





**CERTIFICATIONS**








I,
      Joel
      D. Knudson, certify that:





1. I
      have
      reviewed this quarterly report on Form 10-Q of Criticare Systems,
      Inc.;





2. Based
      on
      my knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;





3. Based
      on
      my knowledge, the financial statements, and other financial information included
      in this report, fairly present in all material respects the financial condition,
      results of operations and cash flows of the registrant as of, and for, the
      periods presented in this report;





4. The
      registrant's other certifying officer and I are responsible for establishing
      and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules
      13a-15(e) and 15d-15(e)) for the registrant and have:





(a) designed
      such disclosure controls and procedures, or caused such disclosure controls
      and
      procedures to be designed under our supervision, to ensure that material
      information relating to the registrant, including its consolidated subsidiaries,
      is made known to us by others within those entities, particularly during the
      period in which this report is being prepared;





(b) evaluated
      the effectiveness of the registrant's disclosure controls and procedures and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this
      report based on such evaluation; and





(c) disclosed
      in this report any change in the registrant’s internal control over financial
      reporting that occurred during the registrant’s most recent fiscal quarter that
      has materially affected, or is reasonably likely to materially affect, the
      registrant’s internal control over financial reporting; and





5. The
      registrant's other certifying officer and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      registrant's auditors and the audit committee of registrant's board of directors
      (or persons performing the equivalent functions):








(a) all
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant's ability to record, process, summarize and
      report financial information; and





(b) any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in the registrant's internal control over financial
      reporting.





Date: 
      May 9, 2006








/s/
      Joel D.
      Knudson


Joel
      D.
      Knudson


Vice
      President - Finance and Secretary






2
Exhibit 35.2

Feb 28, 2014

Servicer Compliance Statement

For SEMT 2013-3 (see Schedule A)



| | (i) | a review of the Servicers activities during the reporting period from January 1, 2013 through December 31, 2013 and of its performance under the Agreement (each of the agreement and the reconstitution
Agreement as defined on Schedule A attached hereto) from the above referenced trust during such period has been made under such officers supervision, and
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (ii) | to the best of such officers knowledge, based on such review, the Servicer has fulfilled all of its obligations under this Agreement and any applicable Reconstitution Agreement in all material respects throughout
such reporting period (or applicable portion thereof) or, if there has been a failure to fulfill any such obligation in any material respect, specifically identifying each such failure known to such officer and the nature and the status thereof.
| | ---- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



First Republic BankBy:

/s/ Lionel AntunesName:

Lionel AntunesTitle:

Vice President of Residential LendingDate:

Feb. 28, 2014




---

<for SEMT 2013-3>

SCHEDULE A



|1. | Flow Mortgage Loan Sale and Servicing Agreement dated as of July 1, 2010, between Redwood Residential Acquisition Corporation and First Republic Bank, as modified by Reconstitution Agreement dated March 1,
2013.
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
TSD Appendix D Percent Contribution from Louisiana Emissions to

Total Visibility Impairment at Class I Areas on 20% Worst Days

Class I Area Abbreviation 2002 2018 BRET1 15.75%24.67% WIMO1 3.47% 4.83% CACR1 2.86%4.23% BIBE1 2.79% 3.32% UPBU1 1.80% 2.71% HEGL1 1.71% 2.43% GUMO1 1.32% 1.57% WHIT1 1.28% 1.44% SIPS1 0.96% 1.78% SACR1 0.93% 1.07% MACA1 0.67% 1.19% SENE1 0.54% 0.77% BOAP1 0.42% 0.48% GRSM1 0.40% 0.83% ISLE1 0.39% 0.49% BADL1 0.36% 0.41% CADI1 0.34% 0.59% GICL1 0.30% 0.37% BOND1 0.27% 0.41% MING1 0.22% 0.33% BAND1 0.21% 0.24% SAPE1 0.20% 0.22% WICA1 0.14% 0.16% WHPE1 0.14% 0.16%
Exhibit 35.1



|     |  |                                                                                   
|---- |  | ----------------------------------------------------------------------------------
|LOGO |  | Corporate Trust Services
 MAC R1204-010
9062 Old Annapolis Road Columbia, MD
21045
|     | 
|     |  | Tel: 410 884 2000                                                                 
|     |  | Fax: 410 715 2380                                                                 

Citibank, N.A.

388 Greenwich
Street

14th Floor

New York, New York 10013

RE: Annual Statement of Compliance for Sequoia Mortgage Trust 2013-3

Per the Amended and Restated Pooling and Servicing dated as of January 1, 2014 (the Agreement), the undersigned, a duly authorized officer of
Wells Fargo Bank, N.A., as Master Servicer (Wells Fargo), hereby certifies as follows as of and for the year

ending December 31, 2014
(the Reporting Period):

(a) A review of Wells Fargos activities during the Reporting Period and of its performance under
the Agreement has been made under such officers supervision; and

(b) To the best of such officers knowledge, based on such
review, Wells Fargo has fulfilled all of its obligations under the Agreement in all material respects throughout the Reporting Period.

February 24,
2015



|                  
|------------------
|/s/ Kristen Cronin
|Kristen Cronin    
|Vice President    



|                       |  |     
|---------------------- |  | ----
|Wells Fargo Bank, N.A. |  | LOGO
**EXHIBIT      32 **

**CERTIFICATIONS      **

**Pursuant      to 18 U.S.C. Section 1350 **

|                                        |                                         |
|---------------------------------------------|----------------------------------------------|
| Date: February                14, 2007 | /s/                Reginald M. Fountain, Jr. |
|                                        | Reginald                M. Fountain, Jr.     |
|                                        | Chief                Executive Officer       |
|                                        |                                         |
|                                        |                                         |
| Date: February                14, 2007 | /s/                Irving L. Smith           |
|                                        | Irving                L. Smith               |
|                                        | Chief                Financial Officer       |

----
427 A.2d 1206

#### Pedano et al. v. Pedano, Appellant.

Argued September 12, 1979.

Edward J. Hughes, for appellant;

Lynne Z. Gold-Bi-kin, for appellees.

Before PRICE, WIEAND and VAN der VOORT, JJ.*

The support order is reduced to $95 per week; and, as so modified, the order is affirmed.

PRICE, J., dissented.
§ 1532.765 How may I appeal my EPA suspension? ( a ) If the EPA suspending official issues a decision under 2 CFR 180.755 to continue your suspension after you present information in opposition to that suspension under 2 CFR 180.720, you can ask for review of the suspending official's decision in two ways: ( 1 ) You may ask the suspending official to reconsider the decision for material errors of fact or law that you believe will change the outcome of the matter; and/or
( 2 ) You may request the Director, Office of Grants and Debarment (OGD Director), to review the suspending official's decision to continue your suspension within 30 days of your receipt of the suspending official's decision under 2 CFR 180.755 or paragraph (a)(1) of this section. However, the OGD Director can reverse the suspending official's decision only where the OGD Director finds that the decision is based on a clear error of material fact or law, or where the OGD Director finds that the suspending official's decision was arbitrary, capricious, or an abuse of discretion.
( b ) A request for review under this section must be in writing; state the specific findings you believe to be in error; and include the reasons or legal bases for your position.
( c ) A review under paragraph (a)(2) of this section is solely within the discretion of the OGD Director who may also stay the suspension pending review of the suspending official's decision.
( d ) The EPA suspending official and the OGD Director must notify you of their decisions under this section, in writing, using the notice procedures at 2 CFR 180.615 and 180.975.
Exhibit 4.27


 


AGREEMENT


 


Pursuant to the Second Amended and Restated Series 2005-1
Supplement, dated as of April 13, 2006 (as amended to date, the “Series 2005-1
Supplement”), by and between ARG Funding Corp. (“ARG”) and The Bank of New
York, as Trustee (“Trustee”) supplementing the Fourth Amended and Restated Base
Indenture, dated as of April 13, 2006 (the “ARG Base Indenture”), by and
between ARG and the Trustee, each of the undersigned agree that effective as of
the date hereof the “Series 2005-1 Maximum Non-Program Vehicle Percentage”
shall be increased from 15% to 30%.


 


Capitalized terms used but not otherwise defined herein are used herein
as defined in the Series 2005-1 Supplement.


 


This Agreement may be executed in any number of counterparts, each
of which so executed shall be deemed an original, but all of such counterparts
shall together constitute but one and the same instrument.


 

















 


IN WITNESS WHEREOF, each of the undersigned have caused this Agreement
to be executed by their respective officers thereunto duly authorized as of the
day and year written below.


 


 


	
   

  	
  ARG
  FUNDING CORP., a special purpose,

    Delaware corporation

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ PHILIP A. MARTONE

  	
   

  
	
   

  	
  Name:

  	
  Philip A. Martone

  	
   

  
	
   

  	
  Title:

  	
  Vice President

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  MBIA
  INSURANCE CORPORATION

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  Dated:
  July 24, 2006

  	
   

  
						



 

















 


IN WITNESS WHEREOF, each of the undersigned have caused this Agreement
to be executed by their respective officers thereunto duly authorized as of the
day and year written below.


 


 


	
   

  	
  ARG
  FUNDING CORP., a special purpose,

    Delaware corporation

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  MBIA
  INSURANCE CORPORATION

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Dana L. Hartman

  	
   

  
	
   

  	
  Name:

  	
  Dana L. Hartman

  	
   

  
	
   

  	
  Title:

  	
  Director

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  Dated:
  July 24, 2006
#### Marion G. Potter et al., Respondents, v. Furniture Manufacturers Building, Inc. et al., Appellants.

Judgment affirmed, with costs. All concur, except Goldman, P. J., who dissents and votes to reverse and grant a new trial as to both defendants in the following Memorandum: The verdict of the jury was against the weight of the credible evidence. (Appeal from judgment of Chautauqua Trial Term in negligence action.) Present— Goldman, P. J., Marsh, Witmer, Moule and Bastow, JJ.
H. Res. 85

In the House of Representatives, U.S., 

March 28, 2006.

Whereas mucopolysaccharidoses and mucolipidoses (commonly known as ‘‘MPS disorders’’) are genetically determined lysosomal storage disorders that result in the inability of the body to produce certain enzymes needed to 

break down complex carbohydrates; 

Whereas in individuals with MPS disorders, complex carbohydrates are stored in virtually every cell in the body and 

progressively cause damage to the cells, affecting multiple 

systems, including the bones, heart and other internal organs, respiratory system, and central nervous system; 

Whereas the cellular damage caused by MPS disorders results in mental retardation, short stature, corneal damage, joint stiffness, loss of mobility, speech and hearing 

impairment, heart disease, hyperactivity, chronic respiratory problems, and, most importantly, drastically 

shortened life span; 

Whereas the nature of MPS disorders is usually not apparent 

at birth, and, without treatment, life expectancy is usually very short; 

Whereas the multisystemic damage that is caused by MPS 

disorders makes the disorders ideal models for many 

other degenerative genetic disorders; 
2

•HRES 85 EH 

Whereas recent research developments have resulted in limited treatments for some MPS disorders, and promising 

advancements are underway in pursuit of treatments for 

additional MPS disorders; 

Whereas treatments and research advancements for MPS disorders are limited by lack of awareness about the disorders, even within the medical community; 

Whereas the development of early detection and intervention 

techniques, effective treatments, and a potential cure for 

MPS disorders can be accomplished by research, data 

collection, and information distribution; 

Whereas increased public and professional awareness and 

continued public funding will assist in the development of 

new techniques, treatments, and cures for MPS disorders, which will greatly enhance the quality of life for 

individuals with MPS disorders; 

Whereas the National MPS Society, Inc., a group ultimately 

dedicated to finding a cure for MPS disorders, has designated February 25 of each year as ‘‘National MPS 

Day’’; and 

Whereas the designation of ‘‘National MPS Day’’ provides an 

opportunity to increase public and professional awareness 

about mucopolysaccharidoses and mucolipidoses, and to 

encourage research for early diagnosis, effective treatments, and a potential cure for MPS disorders: Now, 

therefore, be it
3

•HRES 85 EH 

Resolved, That the House of Representatives supports 

the goals and ideals of ‘‘National MPS Day’’.

Attest: 

Clerk.